Compound Evidence File
#EC-2026-0386
Boldenone Undecylenate (EQ) Raw
Filed under Raw Materials. The bureau holds 119 laboratory returns for this compound from 41 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
41 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Apr 2026 | 26 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 10.0 | 10.0 | 14 Apr 2026 | 24 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 10.0 | 10.0 | 8 Mar 2026 | 18 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Mar 2026 | 4 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 24 Mar 2026 | 8 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Jan 2026 | 26 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 25 May 2026 | 15 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Nov 2025 | 23 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Feb 2026 | 11 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Dec 2025 | 10 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Apr 2026 | 25 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Apr 2026 | 24 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Apr 2026 | 18 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 18 May 2026 | 14 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 16 May 2026 | 19 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Apr 2026 | 25 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Mar 2026 | 18 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Feb 2026 | 22 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 1 Apr 2026 | 20 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 1 Mar 2026 | 19 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 28 Apr 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 9.0 | 7.4 | 10.0 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.9 | 8.5 | 9.4 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.8 | 7.2 | 9.9 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.1 | 6.3 | 9.4 | 24 May 2026 | 24 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 3 | 7.8 | 6.8 | 8.6 | 16 Mar 2025 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 7.6 | 7.0 | 8.2 | 24 May 2026 | 24 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 | 9 Jun 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 7.5 | 5.7 | 9.3 | 11 Jun 2025 | 20 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 2 | 7.2 | 7.0 | 7.3 | 25 Apr 2025 | 17 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 | 14 Jan 2025 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 6.2 | 6.2 | 6.2 | 20 Jun 2025 | 20 Jun 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 5.3 | 5.3 | 5.3 | 13 Feb 2025 | 13 Feb 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 4.4 | 4.4 | 4.4 | 6 May 2025 | 6 May 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 4 | 4.3 | 3.5 | 4.9 | 3 Jun 2025 | 17 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 4.2 | 4.2 | 4.2 | 13 Jun 2025 | 13 Jun 2025 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 4.1 | 3.2 | 5.0 | 6 May 2025 | 19 Jan 2026 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.4 | 0.4 | 0.4 | 7 May 2025 | 7 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for Boldenone Undecylenate (EQ) Raw alone.